Remove Big Data Remove Clinical Research Remove Engineer Remove Medicine
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

article thumbnail

Genmab’s Silver Anniversary: Reflecting on 25 Years of Breakthroughs in Antibody Therapeutics

XTalks

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug discovery in 2023: Five key predictions

Drug Discovery World

According to a survey of 150 biotech and biopharma leaders by clinical research company PPD , leveraging new technologies (including mRNA and drug discovery platforms) is one of the greatest opportunity areas in clinical trials for 2023. . Personalised and precision medicines will dominate pipelines.

Drugs 52
article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. The webinar explored the potential of the technology to process the vast amount of data languishing untapped in EHRs, while ensuring that patient data privacy and safety is maintained at all times.

Big Data 135
article thumbnail

Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center to Disrupt and Accelerate Trial Enrollment, Featuring 72-Hour Instant Enrollment from Time of Patient Identification

The Pharma Data

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process. 13, 2021 13:00 UTC.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Verily’s Immune Profiler platform is “a discovery engine consisting of proprietary immune profiling lab workflow, growing multi-omic database, and advanced analytical tools”. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.